Clinical Characteristics, Electrophysiology, and Skin Biopsy of 38 Peripheral Neuropathy Cases with Small Fiber Involvement of Various Etiologies
- Author:
- No author available
- Journal Title:
- Chinese Medical Journal
- Issue:
- 14
- DOI:
- 10.4103/0366-6999.209897
- Key Word:
- Impaired Glucose Tolerance;Intraepidermal Nerve Fiber Density;Metabolic Syndrome;Nerve Conduction Studies;Small Fiber Neuropathy
Abstract： Background:In small fiber neuropathy (SFN),thinly myelinated Aδ and unmyelinated C fibers are primarily affected,resulting in sensory and/or autonomic symptoms.Various etiologies have been shown to be associated with SFN.This study was aimed to analyze a variety of features in peripheral neuropathy (PN) with small fiber involvement.and to compare disease severity among patients with idiopathic PN,PN associated with impaired glucose tolerance (IGT),and metabolic syndrome (MS) PN.Methods:Thirty-eight PN patients with small fiber involvement were enrolled from December 20,2013 to May 31,2016.Patients were divided into idiopathic PN,IGT-related PN,and MS-related PN groups.Detailed medical history and small fiber neuropathy were investigated,and symptom inventory questionnaire was conducted,as well as the visual analog scale.Nerve conduction studies and skin biopsies were also performed.The differences among the groups were analyzed using analysis of variance and Kruskal-Wallis test.Results:Eight patients were diagnosed with pure SFN.lntraepidermal nerve fiber density (I ENFD) weakly correlated with motor conduction velocity (MCV) (r =0.372,P =0.025),and proximal (r =0.383,P =0.021) and distal (r =0.358,P 0.032) compound muscle action potential (CMAP) of the tibial nerve.IENFD also weakly correlated with MCV of the peroneal nerve (r=0.399,P =0.016).IENFD was shown to be significantly different among all groups (x2 =9.901,P-0.007).IENFD was significantly decreased (x2 =23.000,P=0.003) in the MS-related PN group compared to the idiopathic PN group.The MCV of the tibial nerve was significantly different among all groups (x2 =8.172,P ＜ 0.017).The proximal (F =4.336,P =0.021) and distal (F =3.262,P =0.049) CMAP of the tibial nerve was also significantly different among all groups.Conclusions:IENFD of patients included in the present study weakly correlated with various electrophysiological parameters.Small and large fibers are more involved in patients with MS-related PN than in patients with idiopathic PN.
- [1]Andreas C Themistocleous,Juan D Ramirez,Jordi Serra,etc.The clinical approach to small fibre neuropathy and painful channelopathy.[J].2014,14(6).
- [2]Jianbo Li,Daniel Ontaneda,Ian Zhou.Metabolic Syndrome in Small Fiber Sensory Neuropathy[J].2011,12(4).
- [3]Rose K,Singleton JR,Smith AG.Idiopathic neuropathy patients are at high risk for metabolic syndrome.[J].2008,273(1).
- [4]Henri K, Parson,Van T, Nguyen,Michael-Angelo, Orciga,etc.Contact heat-evoked potential stimulation for the evaluation of small nerve fiber function.[J].2013,15.
- [5]W R, Kennedy,G, Wendelschafer-Crabb.The innervation of human epidermis.[J].1993,115(2).
- [6]Hoitsma E,Reulen JP,de Baets M,etc.Small fiber neuropathy: a common and important clinical disorder.[J].2004,227(1).
- [7]Sumner CJ,Polydefkis M,Sheth S,etc.The spectrum of neuropathy in diabetes and impaired glucose tolerance.[J].2003,60(1).
- [8]Faber,C.G.,Hoeijmakers,J.G.J.,Lauria,G.,etc.Small fibers, large impact: Quality of life in small-fiber neuropathy[J].2014,49(3).
- [9]A Gordon, Smith,J Robinson, Singleton.The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy.[J].2004,164(9).
- [10]Devigili G,Lauria G,Tugnoli V,etc.The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology.[J].2008,131(Pt.7).
- [11]Caplan Louis R..DeJong's The Neurologic Examination[J].1993.
- [12]Loseth, Sissel,Stalberg, Erik V.,Lindal, Sigurd,etc.Small and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5-year follow-up study[J].2016,21(1).
- [13]Novella SP,Inzucchi SE,Goldstein JM.The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy.[J].2001,24(9).
- [14]Shazli, Azmi,Maryam, Ferdousi,Ioannis N, Petropoulos,etc.Corneal Confocal Microscopy Identifies Small-Fiber Neuropathy in Subjects With Impaired Glucose Tolerance Who Develop Type 2 Diabetes.[J].2015,38.
- [15]Hsieh ST,Umapathi T,Bakkers M,etc.Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study.[J].2010,15(3).
- [16]McArthur JC,Cornblath DR,Griffin JW,etc.Intraepidermal nerve fiber density in patients with painful sensory neuropathy.[J].1997,48(3).
- [17]McArthur JC,Hsieh ST,Cornblath DR,etc.Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy.[J].1995,45(10).
- [18]Singleton, J. Robinson,Marcus, Robin L.,Lessard, Margaret K.,etc.Supervised Exercise Improves Cutaneous Reinnervation Capacity in Metabolic Syndrome Patients[J].2015,77(1).
- [19]Bromberg MB,Singleton JR,Smith AG.Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy.[J].2001,24(8).
- [20]Said, G..Small fiber involvement in peripheral neuropathies: editorial review[J].2003,16(5).
- [21]Bakkers M,Merkies IS,Lauria G.Intraepidermal nerve fiber density and its application in sarcoidosis.[J].2009,73(14).
- [22]Dolan, M. Eileen,Brewer, Jamie R.,Morrison, Gladys,etc.Chemotherapy-induced peripheral neuropathy: Current status and progress[J].2016,140(1).
- [23]Divisova, S.,Vlckova, E.,Srotova, I.,etc.Intraepidermal nerve-fibre density as a biomarker of the course of neuropathy in patients with Type2 diabetes mellitus[J].2016,33(5).
- [24]Tadashi Uto,Hiroshi Takashima,Yumiko Arimura,etc.Intraepidermal nerve fiber density and nerve conduction study parameters correlate with clinical staging of diabetic polyneuropathy[J].2013,99(1).
- [25]Ramachandran P,Singleton JR,Smith AG,etc.Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy.[J].2001,57(9).
- [26]Smith AG,Singleton JR,Bromberg MB.Painful sensory polyneuropathy associated with impaired glucose tolerance.[J].2001,24(9).